Improving multiple sclerosis management and collecting safety information in the real world: the MSDS3D software approach.
Rocco HaaseMaria WunderlichAnja DillensegerRaimar KernKatja AkgünTjalf ZiemssenPublished in: Expert opinion on drug safety (2018)
eHealth-enhanced post-authorisation safety study may complete the fundamental quest of RWE for individually improved treatment decisions and balanced therapeutic risk assessment. MSDS3D is carefully designed to contribute to every single objective in this process.